Simon Alvis

Title: Innovations and Patents of Simon Alvis

Introduction: Simon Alvis, an accomplished inventor based in Oxfordshire, GB, has made significant contributions to the field of biotechnology. With a solid background in research and development, Alvis has focused on creating formulations that have potential therapeutic applications, specifically in the area of cancer treatment.

Latest Patents: Simon Alvis holds a patent for a novel liquid formulation containing a group B adenovirus. The patent details a composition that includes a replication-competent group B adenovirus, glycerol (ranging from 15 to 25% v/v), ethanol (0.1 to 1.5% v/v), and a buffer, with the option to include an amino acid. The pH of this formulation is designed to be between 8.0 and 9.6, showcasing its suitability for medical applications, particularly in oncology.

Career Highlights: Alvis currently works at Akamis Bio Limited, where he contributes his expertise in developing innovative biological formulations. His career is marked by a dedication to advancing medical treatments through biotechnological breakthroughs.

Collaborations: Throughout his career, Simon has had the opportunity to collaborate with various talented individuals, including his coworker Magdalena Kieltyka. These collaborations have fostered a dynamic research environment, emphasizing creativity and innovation in the field.

Conclusion: Simon Alvis stands out as a notable inventor with his innovative approach to adenovirus formulations. His patent not only demonstrates his ingenuity but also reflects a deeper commitment to advancing cancer treatment. As he continues to work with Akamis Bio Limited and others in the industry, the potential for future inventions remains promising.